Save the Date | 30 April 2026 | Launch of the EASL–Lancet Commission 2.0
From Evidence to Impact: Implementing Sustainable Liver Health in Europe
🗓 30 April 2026 | 11:00–13:00 CEST
📍 Townhall Europe, Square de Meeûs 5-6, Brussels

Liver disease remains one of Europe’s most pressing yet under-recognised public health challenges. The new EASL–Lancet Commission 2.0 marks a pivotal moment: moving beyond evidence generation to policy implementation, accountability, and measurable impact.

Programme Highlights:

• Opening remarks: Prof Debbie Shawcross (EASL Secretary General)
• Keynote video address: Dr Hans Kluge (WHO Europe Regional Director)
• Why Europe needs a Lancet Liver Commission: Dr Richard Horton (Editor-in-Chief, The Lancet)
• Commission recommendations overview: Prof Tom H. Karlsen (Commission Leader)
• Data-driven insights on the state of liver health in Europe
• High-level panel discussion featuring leaders from OECD, WHO Europe, the European Parliament, public health, clinical medicine, and policy

This event will bring together policymakers, clinicians, researchers, economists, and civil society to translate recommendations into action at EU and national levels.

Join us!